Indoleamine 2,3-Dioxygenase 1 (IDO1) Expression in Biliary Tract Cancers

被引：0
|
作者：
Bavi, Prashant
Hedley, David
Knox, Jennifer J.
Serra, Stefano
机构：
[1] Univ Toronto, Univ Hlth Network, Toronto, ON, Canada
[2] Univ Toronto, Univ Hlth Network, Clin Oncol, Toronto, ON, Canada
来源：
LABORATORY INVESTIGATION | 2017年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
638
引用
收藏
页码：160A / 161A
页数：2
相关论文
共 50 条
  • [1] Indoleamine 2,3-Dioxygenase 1 (IDO1) Expression in Biliary Tract Cancers
    Bavi, Prashant
    Hedley, David
    Knox, Jennifer J.
    Serra, Stefano
    MODERN PATHOLOGY, 2017, 30 : 160A - 161A
  • [2] Inhibition Mechanisms of Indoleamine 2,3-Dioxygenase 1 (IDO1)
    Rohrig, Ute F.
    Reynaud, Aline
    Majjigapu, Somi Reddy
    Vogel, Pierre
    Pojer, Florence
    Zoete, Vincent
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (19) : 8784 - 8795
  • [3] Structure and Plasticity of Indoleamine 2,3-Dioxygenase 1 (IDO1)
    Roehrig, Ute F.
    Michielin, Olivier
    Zoete, Vincent
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (24) : 17690 - 17705
  • [4] Challenges in the Discovery of Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors
    Roehrig, Ute F.
    Majjigapu, Somi Reddy
    Vogel, Pierre
    Zoete, Vincent
    Michiein, Olivier
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (24) : 9421 - 9437
  • [5] Recent advances in the discovery of indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors
    Wang, Xiu-Xiu
    Sun, Si-Yu
    Dong, Qing-Qing
    Wu, Xiao-Xiang
    Tang, Wei
    Xing, Ya-Qun
    MEDCHEMCOMM, 2019, 10 (10) : 1740 - 1754
  • [6] ACTIVATION OF INDOLEAMINE 2,3-DIOXYGENASE 1 (IDO1) IN PATIENTS WITH SYSTEMIC SCLEROSIS
    Del Papa, N.
    Filippini, P.
    De Cristofaro, R.
    Sambataro, D.
    Rovelli, F.
    Vitali, C.
    Locatelli, F.
    Rutella, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 831 - 831
  • [7] Azole-Based Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors
    Rohrig, Ute F.
    Majjigapu, Somi Reddy
    Reynaud, Aline
    Pojer, Florence
    Dilek, Nahzli
    Reichenbach, Patrick
    Ascencao, Kelly
    Irving, Melita
    Coukos, George
    Vogel, Pierre
    Michielin, Olivier
    Zoete, Vincent
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (04) : 2205 - 2227
  • [8] Indoleamine 2,3-dioxygenase 1 (IDO1) regulates immune evasion in lymphoma
    Park, Jihyun
    Yoo, Seung-Joo
    Hu, Qianni
    Fielder, Carly M.
    Yoon, Hyundong
    Hong, Junshik
    Kim, Byung-Su
    Koh, Youngil
    Kim, Tae Kon
    Yoon, Sung-Soo
    Yan, Chi
    CANCER RESEARCH, 2024, 84 (06)
  • [9] Development of 2" generation indoleamine 2,3-dioxygenase 1 (IDO1) selective inhibitors
    Pesnot, Thomas
    Mahale, Sachin
    MacFaul, Philip
    Maclean, John
    Phillips, Caroline
    Bingham, Matilda
    Eagle, Catherine
    Kelly, James
    Thippeswamy, Abhijith
    Armitage, Simon
    Grisin, Aleksandr
    Aiken, Sheenagh
    Cartwright, Lucy
    Armer, Richard
    CANCER RESEARCH, 2017, 77
  • [10] Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors in clinical trials for cancer immunotherapy
    Tang, Kai
    Wu, Ya-Hong
    Song, Yihui
    Yu, Bin
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)
12345